A detailed history of Centre Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Centre Asset Management, LLC holds 47,832 shares of BIIB stock, worth $8.31 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares
47,832
Holding current value
$8.31 Million
% of portfolio
2.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$189.07 - $236.8 $9.04 Million - $11.3 Million
47,832 New
47,832 $9.27 Million
Q2 2023

Jul 06, 2023

BUY
$275.25 - $318.06 $260,111 - $300,566
945 Added 2.8%
34,686 $9.88 Million
Q1 2023

Apr 03, 2023

BUY
$256.56 - $292.34 $138,029 - $157,278
538 Added 1.62%
33,741 $9.38 Million
Q4 2022

Feb 07, 2023

SELL
$252.44 - $306.72 $601,564 - $730,913
-2,383 Reduced 6.7%
33,203 $9.2 Million
Q3 2022

Oct 04, 2022

BUY
$194.69 - $268.46 $6.93 Million - $9.55 Million
35,586 New
35,586 $9.5 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Centre Asset Management, LLC Portfolio

Follow Centre Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centre Asset Management, LLC with notifications on news.